NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
NeuroPace Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$12.77+0.53 (+4.33%)
Close on Oct 19, 2026
- Market cap
- $435.51M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
NeuroPace Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 79.6%
- Operating margin
- -15.3%
- Net margin
- -19.3%
- Return on equity, FY2025
- -158.7%
Financial strength
- Current ratio
- 4.94
- Debt to equity
- 4.97
- Debt to assets
- 60.8%
- Cash to current liabilities
- 71.9%
Valuation
- P/E ratio
- –
- Price to sales
- 4.41
- Price to book
- 36.65
- Dividend yield
- 0.00%